Axiom Real-Time Metrics®

Company Profile

Founded in 2001 and headquartered in the Canadian province of Ontario, Axiom has delivered powerful, cost-effective eClinical solutions to small and medium-sized life science companies worldwide. Axiom’s Fusion eClinical Suite, a unified platform with 15+ integrated modules, including EDC, RTSM, CTMS, ePRO, eTMF, and more, serves as the central hub for clinical trial operations. Alongside its technology, Axiom provides full-service clinical support, including data management, biostatistics, pharmacovigilance, and regulatory compliance.

Situation

Despite a strong operating history and differentiated service offering, Axiom faced macroeconomic pressures, including a decline in new clinical trials across the life sciences sector. In response, the Company implemented several initiatives to streamline operations and preserve liquidity in the face of a changing operating environment.

Solution

In late 2024, SSG was engaged to advise Axiom through this period of strategic and financial transition. SSG worked closely with management and stakeholders to pursue a range of options, including potential sale and financing solutions. As market conditions evolved and liquidity pressures intensified, SSG executed a highly expedited sale process under a Canadian Receivership framework.

Leveraging its deep expertise in life sciences, technology, and special situations, SSG generated significant market engagement and secured multiple indications of interest for the Company. The transaction with Sitero, completed through a court-supervised receivership, preserves Axiom’s technology platform, ensures continuity for its client base, and maximizes value for stakeholders. The outcome reflects SSG’s ability to deliver cross-border strategic solutions under complex and time-sensitive circumstances.